Icks A, Trautner C, Haastert B, Berger M, Giani G
Department of Biometrics and Epidemiology, Diabetes Research Institute at Düsseldorf University, Germany.
Diabet Med. 1997 Jul;14(7):571-5. doi: 10.1002/(SICI)1096-9136(199707)14:7<571::AID-DIA384>3.0.CO;2-Y.
Reducing the incidence of diabetic retinopathy and blindness was declared one of the main objectives in St Vincent. To date, hardly any valid data are available on the age- and sex-specific incidence of diabetes-related blindness. They are necessary, however, to evaluate intervention activities. Therefore, we used a population-based registry of blindness to calculate incidence of blindness due to diabetes. In one German district (Rhineland) we obtained complete lists of cases of blindness newly registered in 1990 and 1991 and coded as blind due to diabetes (n = 589). We estimated age-specific incidence rates in the entire as well as in the diabetic population. Incidence rates of blindness due to diabetes (100,000(-1) * year(-1)), standardized to the West-German population, were 3.2 (CI 95%: 2.9;3.4) in the entire population and 60.5 (CI 95%: 45.7;75.4) in the diabetic population. Incidence rates in the diabetic population showed a peak between 20 and 40 years of age, probably due to complications of Type 1 diabetes. Incidence was higher in diabetic women than in diabetic men (p < 0.05 at ages > or =40 years). Repeating the study will detect a decrease in the incidence of blindness due to diabetes by one-third with over 99% power.
降低糖尿病视网膜病变和失明的发病率被宣布为圣文森特的主要目标之一。迄今为止,几乎没有关于糖尿病相关失明的年龄和性别特异性发病率的有效数据。然而,这些数据对于评估干预活动是必要的。因此,我们使用基于人群的失明登记册来计算糖尿病导致的失明发病率。在德国的一个地区(莱茵兰),我们获得了1990年和1991年新登记的失明病例的完整清单,并将其编码为糖尿病导致的失明(n = 589)。我们估计了整个人群以及糖尿病患者人群中按年龄划分的发病率。根据西德人群进行标准化后,糖尿病导致的失明发病率(每100,000人每年)在整个人群中为3.2(95%置信区间:2.9;3.4),在糖尿病患者人群中为60.5(95%置信区间:45.7;75.4)。糖尿病患者人群中的发病率在20至40岁之间出现峰值,可能是由于1型糖尿病的并发症。糖尿病女性的发病率高于糖尿病男性(年龄≥40岁时p < 0.05)。重复这项研究将发现糖尿病导致的失明发病率降低三分之一,检验效能超过99%。